ACQUISITIONS - Narrative (Details)

v3.23.1

ACQUISITIONS - Narrative (Details)				1 Months Ended										12 Months Ended
	Dec. 18, 2020 dispensary	Jul. 24, 2020 USD ($)	Jan. 29, 2020 USD ($) dispensary $ / shares shares	Sep. 30, 2022	Jul. 31, 2022 USD ($) shares	Apr. 30, 2022 USD ($) ft² dispensary $ / shares shares	Mar. 31, 2022 USD ($) $ / shares shares	Sep. 30, 2021 USD ($) ft² dispensary $ / shares shares	Jul. 31, 2021 USD ($) ft²	Apr. 30, 2021 USD ($)	Mar. 31, 2021 USD ($) $ / shares shares	Jan. 31, 2021 shares	Jul. 31, 2020 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($) shares	Dec. 31, 2019 USD ($)	Jul. 31, 2021 a	Aug. 11, 2020	Jun. 25, 2020	Dec. 31, 2018
Business Acquisition [Line Items]
Contingent consideration liabilities - current portion														$ 3,398,000	$ 0
Other liabilities - non-current														1,395,000	8,223,000
Acquisition related costs														1,204,000	350,000	$ 502,000
Contributed revenues														28,912,000	15,107,000	36,364,000
Contributed net (loss) income														$ (43,603,000)	$ (1,120,000)	7,667,000
Stock price per share
Business Acquisition [Line Items]
Warrants and rights outstanding, measurement input														1.28
Exercise price
Business Acquisition [Line Items]
Warrants and rights outstanding, measurement input														2.00
Remaining life
Business Acquisition [Line Items]
Warrants and rights outstanding, measurement input														1.35
Weighted average volatility
Business Acquisition [Line Items]
Warrants and rights outstanding, measurement input														0.76
Risk-free annual interest rate
Business Acquisition [Line Items]
Warrants and rights outstanding, measurement input														0.0146
Discount Rate
Business Acquisition [Line Items]
Intangible assets, measurement input														0.12
Measurement Input, Growth Rate
Business Acquisition [Line Items]
Intangible assets, measurement input														0
Measurement Input, Useful Life, Minimum
Business Acquisition [Line Items]
Intangible assets, measurement input														9
Measurement Input, Useful Life, Maximum
Business Acquisition [Line Items]
Intangible assets, measurement input														11
PAMS | Affiliated Entity
Business Acquisition [Line Items]
Consideration paid in promissory notes (fair value)													$ 3,000,000
OhiGrow
Business Acquisition [Line Items]
Area of real estate property (in sq ft)									10,000									1.35
Consideration paid in cash, as adjusted for working capital adjustments									$ 4,949,000
Grover Beach
Business Acquisition [Line Items]
Consideration paid in cash, as adjusted for working capital adjustments											$ 3,592,000
Equity acquired				22.00%							78.00%
Equity interest issued and issuable (in shares) | shares											49,348
Equity issued, price per share (in dollars per share) | $ / shares											$ 7.46
Rights to remaining equity											$ 1
Unsecured Debt
Business Acquisition [Line Items]
Debt instrument interest rate														12.00%
Nature's Remedy Three-Year Note | Unsecured Debt
Business Acquisition [Line Items]
Debt instrument term				3 years				3 years
Debt instrument principal amount								$ 11,500,000
Debt instrument interest rate								8.00%
Nature's Remedy Five-Year Note
Business Acquisition [Line Items]
Debt instrument term								5 years
Nature's Remedy Five-Year Note | Unsecured Debt
Business Acquisition [Line Items]
Debt instrument principal amount								$ 5,000,000
Debt instrument interest rate								8.00%
PAMS | Secured Debt
Business Acquisition [Line Items]
Debt instrument interest rate													12.00%
NuLeaf
Business Acquisition [Line Items]
Equity interests acquired						100.00%
Consideration paid in cash, net of working capital adjustments						$ 14,918,000
Equity issued (in shares) | shares						4,662,384
Equity issued, price per share (in dollars per share) | $ / shares						$ 2.91
Debt instrument term					5 years	5 years
Consideration payable in cash (customary hold back liability)						$ 932,000
Contingent liability						10,000,000
Contingent liability, cash						3,000,000
Contingent liability, additional debt						3,000,000
Payment for contingent consideration liability					$ 3,000,000
Payment for contingent consideration liability, net					$ 2,657,000
Equity interest issued to settle contingent liability (in shares) | shares					888,880
Equity interest issued to settle contingent liability					$ 1,529,000
Consideration paid in promissory notes (fair value)						12,860,000
Contingent consideration liabilities - current portion						$ 7,989,000
NuLeaf | Las Vegas, Nevada
Business Acquisition [Line Items]
Number of retail dispensaries | dispensary						2
NuLeaf | Las Vegas Boulevard, Nevada
Business Acquisition [Line Items]
Number of retail dispensaries | dispensary						1
NuLeaf | Sparks, Nevada
Business Acquisition [Line Items]
Area of real estate property (in sq ft) | ft²						27,000
NuLeaf | Reno, Nevada
Business Acquisition [Line Items]
Area of real estate property (in sq ft) | ft²						13,000
NuLeaf | Nuleaf Unsecured Promissory Notes | Unsecured Debt
Business Acquisition [Line Items]
Debt instrument principal amount						$ 15,750,000
Senior notes, fair value						$ 12,860,000
Debt instrument interest rate						8.00%
Apothecarium
Business Acquisition [Line Items]
Equity interests acquired							100.00%
Consideration paid in cash, net of working capital adjustments							$ 6,703,000
Equity issued (in shares) | shares							527,704
Equity issued, price per share (in dollars per share) | $ / shares							$ 3.02
Debt instrument term							5 years
Consideration payable in cash (customary hold back liability)							$ 0
Consideration paid in promissory notes (fair value)							9,853,000
Consideration paid in promissory notes (fair value)							6,922,000
Contingent consideration liabilities - current portion							$ 0
Nature’s Remedy
Business Acquisition [Line Items]
Equity interests acquired								100.00%
Number of retail dispensaries | dispensary								2
Area of real estate property (in sq ft) | ft²								50,000
Equity issued (in shares) | shares								8,700,000
Equity issued, price per share (in dollars per share) | $ / shares								$ 4.10
Contingent liability								$ 8,223,000
Payment for contingent consideration liability					$ 5,000,000
Consideration paid in promissory notes (fair value)								15,345,000
Contingent consideration, equity interest issued and issuable								5,000,000
Minimum contingent consideration								0
Maximum contingent consideration								10,800,000
Contingent consideration liabilities - current portion														$ 3,398,000
Other liabilities - non-current														1,395,000
Consideration paid in cash, net of working capital adjustments								$ 40,360,000
Nature’s Remedy | First Milestone Period
Business Acquisition [Line Items]
Contingent consideration period								12 months
Nature’s Remedy | Second Milestone Period
Business Acquisition [Line Items]
Contingent liability														4,793,000
Contingent consideration period								18 months
Nature’s Remedy | Nature's Remedy Three-Year Note
Business Acquisition [Line Items]
Debt instrument term				3 years				3 years
Contingent liability, additional debt								$ 5,000,000						5,000,000
Consideration paid in promissory notes (fair value)								$ 11,500,000
Maximum contingent consideration, net														$ 4,708,000
Nature’s Remedy | Nature's Remedy Five-Year Note
Business Acquisition [Line Items]
Debt instrument term								5 years
Consideration paid in promissory notes (fair value)								$ 5,000,000
OSD
Business Acquisition [Line Items]
Equity interests acquired										100.00%
Consideration paid in promissory notes (fair value)										$ 3,100,000
Consideration paid in promissory notes (fair value)										2,429,000
Consideration paid in cash, net of working capital adjustments										$ 1,827,000
PAMS
Business Acquisition [Line Items]
Equity interests acquired																			100.00%
Consideration paid in promissory notes (fair value)																2,658,000
Consideration paid in cash, net of working capital adjustments																15,054,000
PADS
Business Acquisition [Line Items]
Equity interests acquired	100.00%
Purchase option, expiration period	18 months
Number of businesses acquired | dispensary	2
Payments to acquire business, purchase option																1,553,000
Purchase option, gain (loss)																440,000
Consideration paid in cash, net of working capital adjustments																5,671,000
TGS Transaction
Business Acquisition [Line Items]
Equity interests acquired			75.00%																		51.00%
Equity issued (in shares) | shares			416,060
Contingent liability			$ 8,500,000
Consideration paid in promissory notes (fair value)			$ 12,000,000
Number of businesses acquired | dispensary			2
Percentage of voting interests returned			51.00%
Fee amount			$ 2,442,000
Liabilities incurred, convertible debt			$ 9,555,000
Percentage of voting interests acquired, option to purchase			49.00%
Percentage of voting interests acquired, option to purchase, period			30 months
Contingent consideration, liability, fair value																$ 8,440,000
TGS Transaction | Subordinate Voting Shares
Business Acquisition [Line Items]
Derivative warrants exercise price (in dollars per share) | $ / shares			$ 2.00
TGS Transaction | Subordinate Voting Shares
Business Acquisition [Line Items]
TGS Transaction (in shares) | shares																5,000,000
Derivative warrants exercises (in shares) | shares			2,500,000
GSG Santa Barbara
Business Acquisition [Line Items]
Equity interests acquired		100.00%
Consideration paid in cash, net of working capital adjustments		$ 4,900,000															$ 2,250,000
Agape
Business Acquisition [Line Items]
Equity interests acquired												20.00%								80.00%
Equity issued (in shares) | shares												500,000